ReviewBiomarker research2024

Harnessing natural killer cells for refractory/relapsed non-Hodgkin lymphoma: biological roles, clinical trials, and future prospective.

Mehdi Bakhtiyaridovvombaygi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.